Prognostic value of prostate circulating cells detection in prostate cancer patients: a prospective study.
about
Molecular preservation by extraction and fixation, mPREF: a method for small molecule biomarker analysis and histology on exactly the same tissue.Quantitative ratiometric discrimination between noncancerous and cancerous prostate cells based on neuropilin-1 overexpression.Circulating Prostate Cells Found in Men with Benign Prostate Disease Are P504S Negative: Clinical Implications.Markers for detection of prostate cancer.Bridging population and tissue scale tumor dynamics: a new paradigm for understanding differences in tumor growth and metastatic disease.Perioperative Search for Circulating Tumor Cells in Patients Undergoing Prostate Brachytherapy for Clinically Nonmetastatic Prostate Cancer.The current role of circulating tumor cells in the diagnosis and management of bone metastases in advanced prostate cancer.Isolated, disseminated and circulating tumour cells in prostate cancer.Systemic Par-4 inhibits non-autochthonous tumor growth.A comparative performance analysis of total PSA, percentage free PSA, PSA velocity, and PSA density versus the detection of primary circulating prostate cells in predicting initial prostate biopsy findings in Chilean men.Primary circulating prostate cells are not detected in men with low grade small volume prostate cancer.Prediction model for early biochemical recurrence after radical prostatectomy based on the Cancer of the Prostate Risk Assessment score and the presence of secondary circulating prostate cells.Minimal residual disease in prostate cancer patients after primary treatment: theoretical considerations, evidence and possible use in clinical managementThe presence of secondary circulating prostate tumour cells determines the risk of biochemical relapse for patients with low- and intermediate-risk prostate cancer who are treated only with external radiotherapy
P2860
Q31043717-2E672611-6832-4ECE-93D1-CDF8D4005CDCQ35288530-557A5530-9EBA-4097-BDFE-EDCE00A88256Q36838281-969F69EC-2388-473B-80BB-C7143FC22AE3Q37328403-93E74D05-946F-4E06-9744-BD6B18AAD641Q37552264-B619827B-782E-46D0-AABF-B59CA161E26EQ37631572-AFA80FC8-6B19-4CD5-A22F-420FC68B0ACDQ37992696-E103D395-1804-4D4A-82AB-AB9D620E29C4Q38024987-EA356686-5C94-400B-BA3E-417AD7BB27D7Q39536273-C1151053-A0CD-4B34-ADCA-4419BED58D04Q42738041-B4782125-969B-4F16-AF97-783E45072F42Q42858419-DE8FD92C-93DA-4E43-AA6E-0216912734EEQ53298274-DE1EE1DC-6A00-4091-B83C-621E4CD2E8D8Q57106381-659205A3-586B-4DFD-8C13-EDE8422F5863Q57111183-5B58268D-3BA6-463A-905D-448BE95A17D3
P2860
Prognostic value of prostate circulating cells detection in prostate cancer patients: a prospective study.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Prognostic value of prostate c ...... patients: a prospective study.
@en
Prognostic value of prostate c ...... patients: a prospective study.
@nl
type
label
Prognostic value of prostate c ...... patients: a prospective study.
@en
Prognostic value of prostate c ...... patients: a prospective study.
@nl
prefLabel
Prognostic value of prostate c ...... patients: a prospective study.
@en
Prognostic value of prostate c ...... patients: a prospective study.
@nl
P2093
P2860
P356
P1476
Prognostic value of prostate c ...... patients: a prospective study.
@en
P2093
P Eschwège
S Moutereau
P2860
P2888
P304
P356
10.1038/SJ.BJC.6604912
P407
P577
2009-02-01T00:00:00Z